Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 401–500 of 1,133
The transcriptional and signalling networks of pluripotency
Ng, H.-H., & Surani, M. A. (2011) · Nature Cell Biology · doi:10.1038/ncb0511-490 · Cited by 327
“Reprogramming of human somatic cells into induced pluripotent stem cells (iPSCs) was first achieved by ectopic expression of OCT4 , SOX2 , KLF4 and c-MYC or OCT4 , SOX2 , LIN28 and NANOG”
BackgroundAlu element‐mediated gene silencing
Chen, L., DeCerbo, J. N., & Carmichael, G. G. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.94 · Cited by 328
“…and stress granules in pluripotent cells, suggesting that it might influence the translation or stability of specific mRNAs during differentiation (Balzer and Moss, 2007) and that this protein appears to be one of four that together can reprogramme somatic cells to ES cells (Yu et al, 2007).”
BackgroundTelomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients
Agarwal, S., Loh, Y.-H., McLoughlin, E. M., Huang, J., Park, I.-H., Miller, J. D., Huo, H., Okuka, M., dos Reis, R. M., Loewer, S., et al. (2010) · Nature · doi:10.1038/nature08792 · Cited by 321
Induction of human cardiomyocyte-like cells from fibroblasts by defined factors
Wada, R., Muraoka, N., Inagawa, K., Yamakawa, H., Miyamoto, K., Sadahiro, T., Umei, T., Kaneda, R., Suzuki, T., Kamiya, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304053110 · Cited by 327
“Generation of human iPSCs and neuronal cells also required different culture conditions or other transcription factors in addition to the mouse reprogramming factors (21, 22).”
BackgroundSOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
Herreros-Villanueva, M., Zhang, J.-S., Koenig, A., Abel, E. V., Smyrk, T. C., Bamlet, W. R., de Narvajas, A. A.-M., Gomez, T. S., Simeone, D. M., Bujanda, L., et al. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.23 · Cited by 331
Nuclear Reprogramming in Cells
Gurdon, J. B., & Melton, D. A. (2008) · Science · doi:10.1126/science.1160810 · Cited by 322
Reprogramming of T Cells from Human Peripheral Blood
Loh, Y.-H., Hartung, O., Li, H., Guo, C., Sahalie, J. M., Manos, P. D., Urbach, A., Heffner, G. C., Grskovic, M., Vigneault, F., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.004 · Cited by 320
Bilican, B., Serio, A., Barmada, S. J., Nishimura, A. L., Sullivan, G. J., Carrasco, M., Phatnani, H. P., Puddifoot, C. A., Story, D., Fletcher, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202922109 · Cited by 328
Stem cell-delivery therapeutics for periodontal tissue regeneration
Chen, F.-M., Sun, H.-H., Lu, H., & Yu, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.048 · Cited by 324
Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells
Taapken, S. M., Nisler, B. S., Newton, M. A., Sampsell-Barron, T. L., Leonhard, K. A., McIntire, E. M., & Montgomery, K. D. (2011) · Nature Biotechnology · doi:10.1038/nbt.1835 · Cited by 327
Cell-scaffold interactions in the bone tissue engineering triad
Orthopaedic Research and Biotechnology, R. B., Murphy, C., O’Brien, F., Little, D., & Schindeler, A. (2013) · European Cells and Materials · doi:10.22203/ecm.v026a09 · Cited by 312
“However, the vast differential potential of ES and iPS cells is assessed by the ability of these cells to form teratomas (Thomson et al., 1998; Yu et al., 2007; Zhang et al., 2008).”
BackgroundHuman pluripotent stem cell-derived neural constructs for predicting neural toxicity
Schwartz, M. P., Hou, Z., Propson, N. E., Zhang, J., Engstrom, C. J., Costa, V. S., Jiang, P., Nguyen, B. K., Bolin, J. M., Daly, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516645112 · Cited by 325
“Author contributions: M.P.S., Z.H., N.E.P., J.Z., R.S., C.D.P., W.L.M., and J.A. pluripotent stem (iPS) cells (22, 23) now offer a scalable source for tissue-specific cell types.”
BackgroundSelf-citationDNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time
Nishino, K., Toyoda, M., Yamazaki-Inoue, M., Fukawatase, Y., Chikazawa, E., Sakaguchi, H., Akutsu, H., & Umezawa, A. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002085 · Cited by 314
“Transformation of iPSCs from somatic cells requires a process of epigenetic reprogramming promoted by transient ectopic expression of defined transcription factors expressed in ESCs [8–11].”
A Mesoderm-Derived Precursor for Mesenchymal Stem and Endothelial Cells
Vodyanik, M. A., Yu, J., Zhang, X., Tian, S., Stewart, R., Thomson, J. A., & Slukvin, I. I. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.011 · Cited by 315
“Human ESC (H1, H13, H9) (Thomson et al., 1998) lines were obtained from WiCell Research Institute. iPSCs (iPS(IMR)-90-1 and iPS(FSK)-1) were generated by reprogramming fetal and neonatal fibroblasts using lentiviral vectors (Yu et al., 2007).”
InfluentialSelf-citationRuiz, S., Panopoulos, A. D., Herrerías, A., Bissig, K.-D., Lutz, M., Berggren, W. T., Verma, I. M., & Izpisua Belmonte, J. C. (2011) · Current Biology · doi:10.1016/j.cub.2010.11.049 · Cited by 317
Phosphorylation Dynamics during Early Differentiation of Human Embryonic Stem Cells
Van Hoof, D., Muñoz, J., Braam, S. R., Pinkse, M. W. H., Linding, R., Heck, A. J. R., Mummery, C. L., & Krijgsveld, J. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.021 · Cited by 323
“Ectopic expression of LIN28 contributes to formation of iPSCs, illustrating the importance of this pathway in regulating the pluripotent state (Yu et al., 2007).”
BackgroundTranscriptional Signature and Memory Retention of Human-Induced Pluripotent Stem Cells
Marchetto, M. C. N., Yeo, G. W., Kainohana, O., Marsala, M., Gage, F. H., & Muotri, A. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007076 · Cited by 310
“Subsequently, this method was applied to human cells using the same factors or a different combination in a lentivirus vector (Oct4, Sox2, Lin28 and Nanog) [2–5].”
MethodEpigenetic resetting of human pluripotency
Guo, G., von Meyenn, F., Rostovskaya, M., Clarke, J., Dietmann, S., Baker, D., Sahakyan, A., Myers, S., Bertone, P., Reik, W., et al. (2017) · Development · doi:10.1242/dev.146811 · Cited by 319
Dishing out mini-brains: Current progress and future prospects in brain organoid research
Kelava, I., & Lancaster, M. A. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.06.037 · Cited by 310
Bharadwaj, S., Liu, G., Shi, Y., Wu, R., Yang, B., He, T., Fan, Y., Lu, X., Zhou, X., Liu, H., et al. (2013) · Stem Cells · doi:10.1002/stem.1424 · Cited by 322
Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18
Kapoor, N., Liang, W., Marbán, E., & Cho, H. C. (2013) · Nature Biotechnology · doi:10.1038/nbt.2465 · Cited by 321
Somatic Cell Nuclear Transfer Reprogramming: Mechanisms and Applications
Matoba, S., & Zhang, Y. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.06.018 · Cited by 307
FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency
Mossahebi-Mohammadi, M., Quan, M., Zhang, J.-S., & Li, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00079 · Cited by 305
“, 1998), induced pluripotent stem cells (iPSCs) produced by the reprograming of somatic cells from mouse and human by means of the coercive expression of octamer-binding transcription factor 4 (Oct4; Pou5F1), sex determining region Y box 2 (Sox2), krueppellike factor 4 (Klf4), and c-Myc (Takahashi and Yamanaka, 2006;…”
BackgroundNotch Signaling in the Regulation of Stem Cell Self-Renewal and Differentiation
Liu, J., Sato, C., Cerletti, M., & Wagers, A. (2010) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92012-7 · Cited by 311
Regulation of Self-Renewal and Pluripotency by Sox2 in Human Embryonic Stem Cells
Fong, H., Hohenstein, K. A., & Donovan, P. J. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1002 · Cited by 304
Zbinden, M., Duquet, A., Lorente‐Trigos, A., Ngwabyt, S., Borges, I., & Ruiz i Altaba, A. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.137 · Cited by 309
“It is also involved in the reprogramming of differentiated cells towards the ES-like phenotype of induced pluripotent stem (iPS) cells by reprogramming gene sets that include OCT4 and SOX2 (Takahashi and Yamanaka, 2006; Yu et al, 2007).”
BackgroundMethodOrgan-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Cancer stem cells in colorectal cancer: a review
Munro, M. J., Wickremesekera, S. K., Peng, L., Tan, S. T., & Itinteang, T. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204739 · Cited by 304
“20 Noting that c-Myc expression causes death in human ESCs, a similar experiment in 2007 by Yu et al 38 produced iPSCs from human primary fibroblasts using OCT4, SOX2, NANOG and LIN28.”
MethodMicroRNAs and developmental timing
Ambros, V. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.04.003 · Cited by 314
“A possible inverse relationship between microRNA expression and pluripotency of Embryonic Stem (ES) cells emerged from the finding that LIN-28 could act, together with three other proteins, to induce the reprogramming of human somatic cells to pluripotent stem cells [60].”
BackgroundLi, Y., Wang, H., Muffat, J., Cheng, A. W., Orlando, D. A., Lovén, J., Kwok, S.-M., Feldman, D. A., Bateup, H. S., Gao, Q., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.09.001 · Cited by 308
“With the advent of induced pluripotent stem cell (iPSC) technology (Takahashi et al., 2007; Yu et al., 2007), it has become feasible to confirm conclusions from animal models in human cells by deriving patient-specific iPSCs for disease modeling and therapeutic investigation (Ananiev et al., 2011;…”
Fatty Acids Enhance the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Yang, X., Rodriguez, M. L., Leonard, A., Sun, L., Fischer, K. A., Wang, Y., Ritterhoff, J., Zhao, L., Kolwicz, S. C., Pabon, L., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.013 · Cited by 304
“Undifferentiated human IMR90-induced pluripotent stem cells, originally derived from lung fibroblasts (Yu et al., 2007) (James A.”
BackgroundMoradi, S., Mahdizadeh, H., Šarić, T., Kim, J., Harati, J., Shahsavarani, H., Greber, B., & Moore, J. B. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1455-y · Cited by 287
Efficient generation of human iPSCs by a synthetic self-replicative RNA
Yoshioka, N., Gros, E., Li, H.-R., Kumar, S., Deacon, D. C., Maron, C., Muotri, A. R., Chi, N. C., Fu, X.-D., Yu, B. D., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.001 · Cited by 312
“The generation of human induced pluripotent stem cells (hiPSCs) by retroviral expression of four reprogramming factors opened the potential for regenerative medicine therapies based on patient-specific, personalized stem cells (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007).”
Chamberlain, S. J., Chen, P.-F., Ng, K. Y., Bourgois-Rocha, F., Lemtiri-Chlieh, F., Levine, E. S., & Lalande, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004487107 · Cited by 312
“iPSCs were generated using retroviral vectors encoding OCT4, SOX2, KLF4, MYC, and LIN28 (12, 13).”
MethodRNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
Fabbiano, F., Corsi, J., Gurrieri, E., Trevisan, C., Notarangelo, M., & D'Agostino, V. G. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12043 · Cited by 302
Sebastiano, V., Maeder, M. L., Angstman, J. F., Haddad, B., Khayter, C., Yeo, D. T., Goodwin, M. J., Hawkins, J. S., Ramirez, C. L., Batista, L. F. Z., et al. (2011) · Stem Cells · doi:10.1002/stem.718 · Cited by 307
Role of Oct4 in maintaining and regaining stem cell pluripotency
Shi, G., & Jin, Y. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt39 · Cited by 294
“After transcription, Lin28 recruits RNA helicase A to promote the translation of Oct4 mRNA, while miRNAs (including miR-134 and miR-470) cause its decay.”
BackgroundMethodInfluentialZhu, H., Shah, S., Shyh-Chang, N., Shinoda, G., Einhorn, W. S., Viswanathan, S. R., Takeuchi, A., Grasemann, C., Rinn, J. L., Lopez, M. F., et al. (2010) · Nature Genetics · doi:10.1038/ng.593 · Cited by 309
“elegans as heterochronic regulators of larval and vulval development, but recently have been implicated in cancer, stem cell aging, and pluripotency [10-13].”
BackgroundGeneration of oligodendroglial cells by direct lineage conversion
Yang, N., Zuchero, J. B., Ahlenius, H., Marro, S., Ng, Y. H., Vierbuchen, T., Hawkins, J. S., Geissler, R., Barres, B. A., & Wernig, M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2564 · Cited by 303
“Based on our experience with iPS and iN cells, we predict that generation of human iOPCs is possible but may require additional reprogramming factors, such as other transcriptional regulators or microRNAs 15, 35-37 .”
Papapetrou, E. P., Lee, G., Malani, N., Setty, M., Riviere, I., Tirunagari, L. M. S., Kadota, K., Roth, S. L., Giardina, P., Viale, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1717 · Cited by 299
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Kolls, J. K., Ortiz, L. A., Panoskaltsis-Mortari, A., & Prockop, D. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200804-037dw · Cited by 309
Small RNA-mediated regulation of iPS cell generation: RNA-based iPSC reprogramming
Li, Z., Yang, C.-S., Nakashima, K., & Rana, T. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.2 · Cited by 302
“Only MEFs at passage of 0–4 were used for iPS induction. pMX-Oct4, Sox2, Klf4 and cMyc were purchased from Addgene. pMX-HA-p21 was generated by inserting N-terminally tagged-p21 into the pMX EcoRI site. pLKO-shRNA clones were purchased from Open Biosystems.”
BackgroundInfluentialInduction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers
Shu, J., Wu, C., Wu, Y., Li, Z., Shao, S., Zhao, W., Tang, X., Yang, H., Shen, L., Zuo, X., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.001 · Cited by 305
“Accordingly, the reprogramming factors that induce pluripotency have been identified primarily from embryonic stem cell (ESC)-enriched factors, pluripotency-associated factors, or maternal factors such as Oct4, Sox2, Klf4, c-Myc, Nanog, PRDM14, Sall4, Esrrb, Utf1, Tet2, and Glis1 (Aoi et al., 2008; Buganim et al., 201…”
Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues
Ren, G., Chen, X., Dong, F., Li, W., Ren, X., Zhang, Y., & Shi, Y. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0019 · Cited by 307
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience
Mertens, J., Marchetto, M. C., Bardy, C., & Gage, F. H. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.46 · Cited by 307
Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency
Hotta, A., Cheung, A. Y. L., Farra, N., Vijayaragavan, K., Séguin, C. A., Draper, J. S., Pasceri, P., Maksakova, I. A., Mager, D. L., Rossant, J., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1325 · Cited by 300
Prospects for Stem Cell-Based Therapy
Daley, G. Q., & Scadden, D. T. (2008) · Cell · doi:10.1016/j.cell.2008.02.009 · Cited by 302
“This work has been corroborated by others in the murine (Maherali et al., 2007; Wernig et al., 2007) and human (Park et al., 2008; Yu et al., 2007) systems.”
Byers, B., Cord, B., Nguyen, H. N., Schüle, B., Fenno, L., Lee, P. C., Deisseroth, K., Langston, J. W., Pera, R. R., & Palmer, T. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026159 · Cited by 302
“…and Ctrl-HDF were reprogrammed by induced expression of the exogenous transcription factors OCT4 , SOX2 , KLF4 , and c-MYC , through retroviral gene insertion [18,19,20,21,22], and resulting iPSC clones were expanded and characterized for human embryonic stem cell (hESC)-like properties (Fig.”
Introduction to Stem Cell Therapy
Biehl, J. K., & Russell, B. (2009) · Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318197a6a5 · Cited by 284
“One group also added Klf4 and c-Myc,(4) and the other group added Lin28 and Nanog.(6) Other combinations of factors would probably also work, but unfortunately, neither the retroviral carrier method nor the use of the oncogenic transcription factor c-Myc is likely to be approved for human therapy.”
Models of human core transcriptional regulatory circuitries
Saint-André, V., Federation, A. J., Lin, C. Y., Abraham, B. J., Reddy, J., Lee, T. I., Bradner, J. E., & Young, R. A. (2016) · Genome Research · doi:10.1101/gr.197590.115 · Cited by 298
“2006), and can be used to reprogram fibroblasts to an induced pluripotent state (Takahashi and Yamanaka 2006; Yu et al. 2007).”
BackgroundDifferentiated human stem cells resemble fetal, not adult, β cells
Hrvatin, S., O’Donnell, C. W., Deng, F., Millman, J. R., Pagliuca, F. W., DiIorio, P., Rezania, A., Gifford, D. K., & Melton, D. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400709111 · Cited by 302
“Proc Natl Acad Sci USA 100(3):1438–1443.”
Rodin, S., Antonsson, L., Niaudet, C., Simonson, O. E., Salmela, E., Hansson, E. M., Domogatskaya, A., Xiao, Z., Damdimopoulou, P., Sheikhi, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4195 · Cited by 292
Kaufmann, K. B., Büning, H., Galy, A., Schambach, A., & Grez, M. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202287 · Cited by 276
“This seminal fi nding set the stage to generate disease ‐ speci fi c human iPSC from patients ’ somatic cells (Park et al, 2008; Yu et al, 2007).”
Lahti, A. L., Kujala, V. J., Chapman, H., Koivisto, A.-P., Pekkanen-Mattila, M., Kerkelä, E., Hyttinen, J., Kontula, K., Swan, H., Conklin, B. R., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008409 · Cited by 288
“Induced pluripotent stem cell (iPSC) technology (Takahashi et al., 2007; Yu et al., 2007) has revolutionized research on genetic Disease Models & Mechanisms 5, 220-230 (2012) doi:10.1242/dmm.008409 1Institute of Biomedical Technology, and 2BioMediTech, University of Tampere, Biokatu 6-12, 33520…”
InfluentialOrganoids: The current status and biomedical applications
Yang, S., Hu, H., Kung, H., Zou, R., Dai, Y., Hu, Y., Wang, T., Lv, T., Yu, J., & Li, F. (2023) · MedComm · doi:10.1002/mco2.274 · Cited by 266
Self-citationTurning straw into gold: directing cell fate for regenerative medicine
Cohen, D. E., & Melton, D. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2938 · Cited by 287
“Although the cocktail of factors discovered for the reprogramming of somatic cells to iPSCs was successfully translated to human cell”
BackgroundChen, A. K.-L., Reuveny, S., & Oh, S. K. W. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.006 · Cited by 292
Extrinsic regulation of pluripotent stem cells
Pera, M. F., & Tam, P. P. L. (2010) · Nature · doi:10.1038/nature09228 · Cited by 287
Totipotency, Pluripotency and Nuclear Reprogramming
Mitalipov, S., & Wolf, D. (2009) · Engineering of Stem Cells · doi:10.1007/10_2008_45 · Cited by 262
“In November of 2007, two independent groups led by Shinya Yamanaka and James Thomson reported that using a similar transduction approach they were able to generate iPS cells from human somatic cells [66,67].”
BackgroundCell therapy for cardiac repair—lessons from clinical trials
Behfar, A., Crespo-Diaz, R., Terzic, A., & Gersh, B. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.9 · Cited by 292
Can cancer be reversed by engineering the tumor microenvironment?
Ingber, D. E. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.016 · Cited by 298
Biologic properties and enucleation of red blood cells from human embryonic stem cells
Lu, S.-J., Feng, Q., Park, J. S., Vida, L., Lee, B.-S., Strausbauch, M., Wettstein, P. J., Honig, G. R., & Lanza, R. (2008) · Blood · doi:10.1182/blood-2008-05-157198 · Cited by 293
LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells
Zhu, P., Wang, Y., Wu, J., Huang, G., Liu, B., Ye, B., Du, Y., Gao, G., Tian, Y., He, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms13608 · Cited by 302
“KLF4, together with other three Yama-naka pluripotency factors, is able to reprogramme adult fibro-blasts into induced pluripotent cells 28,29 .”
Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery
Sharma, A., Sances, S., Workman, M. J., & Svendsen, C. N. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.02.011 · Cited by 296
“While several adult human cell types such as neurons and cardiomyocytes are difficult to isolate and culture ex vivo, human induced pluripotent stem cell (hiPSC)-derived cells can now overcome this hurdle (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundIsolation of single-base genome-edited human iPS cells without antibiotic selection
Miyaoka, Y., Chan, A. H., Judge, L. M., Yoo, J., Huang, M., Nguyen, T. D., Lizarraga, P. P., So, P.-L., & Conklin, B. R. (2014) · Nature Methods · doi:10.1038/nmeth.2840 · Cited by 301
Ledran, M. H., Krassowska, A., Armstrong, L., Dimmick, I., Renström, J., Lang, R., Yung, S., Santibanez-Coref, M., Dzierzak, E., Stojkovic, M., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.06.001 · Cited by 291
Generation of Human Striatal Neurons by MicroRNA-Dependent Direct Conversion of Fibroblasts
Victor, M. B., Richner, M., Hermanstyne, T. O., Ransdell, J. L., Sobieski, C., Deng, P.-Y., Klyachko, V. A., Nerbonne, J. M., & Yoo, A. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.016 · Cited by 295
“The generation of induced pluripotent stem cells (iPSCs) holds great promise for regenerative medicine and the study of human diseases (Takahashi and Yamanaka, 2006; Yu et al., 2007).”
Repairing the human brain after stroke. II. Restorative therapies
Cramer, S. C. (2008) · Annals of Neurology · doi:10.1002/ana.21412 · Cited by 285
Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation
Zaret, K. S. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2318 · Cited by 290
“Nevertheless, the ability to create ES-like cells from different genetic backgrounds, including from human cell”
BackgroundA comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs
Choi, J., Lee, S., Mallard, W., Clement, K., Tagliazucchi, G. M., Lim, H., Choi, I. Y., Ferrari, F., Tsankov, A. M., Pop, R., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3388 · Cited by 281
Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9
Shin, J. W., Kim, K.-H., Chao, M. J., Atwal, R. S., Gillis, T., MacDonald, M. E., Gusella, J. F., & Lee, J.-M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw286 · Cited by 276
Ghosh, Z., Wilson, K. D., Wu, Y., Hu, S., Quertermous, T., & Wu, J. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008975 · Cited by 281
“plethora of reports have been published showing derivation of iPSCs from various murine and human tissues [6,7,8,9,10], including human iPSCs (hiPSCs) that were derived from multiple”
BackgroundArmstrong, L., Tilgner, K., Saretzki, G., Atkinson, S. P., Stojkovic, M., Moreno, R., Przyborski, S., & Lako, M. (2010) · Stem Cells · doi:10.1002/stem.307 · Cited by 289
Mae, S.-I., Shono, A., Shiota, F., Yasuno, T., Kajiwara, M., Gotoda-Nishimura, N., Arai, S., Sato-Otubo, A., Toyoda, T., Takahashi, K., et al. (2013) · Nature Communications · doi:10.1038/ncomms2378 · Cited by 291
Mali, P., Ye, Z., Hommond, H. H., Yu, X., Lin, J., Chen, G., Zou, J., & Cheng, L. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0346 · Cited by 291
Progress in understanding reprogramming to the induced pluripotent state
Plath, K., & Lowry, W. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2955 · Cited by 289
Bloor, A. J. C., Patel, A., Griffin, J. E., Gilleece, M. H., Radia, R., Yeung, D. T., Drier, D., Larson, L. S., Uenishi, G. I., Hei, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1050-x · Cited by 284
Self-citationChen, G., Hou, Z., Gulbranson, D. R., & Thomson, J. A. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.017 · Cited by 283
“1) (Yu et al., 2007) (Table S1).”
Self-citationTranslation of Human-Induced Pluripotent Stem Cells
Sayed, N., Liu, C., & Wu, J. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.083 · Cited by 279
“These improvements include the use of chemical agents to enhance efficiency (BIX-01294, valproic acid, RG108, AZA [5-aza-20-deoxycytidine], dexamethasone, TSA [trichostatin A], and A-83-01) (10,11), use of alternative cell sources for reprogramming (embryonic, fetal, and adult fibroblasts; neural stem cells; adipose s…”
Modeling ALS with motor neurons derived from human induced pluripotent stem cells
Sances, S., Bruijn, L. I., Chandran, S., Eggan, K., Ho, R., Klim, J. R., Livesey, M. R., Lowry, E., Macklis, J. D., Rushton, D., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4273 · Cited by 289
A predictive computational framework for direct reprogramming between human cell types
The FANTOM Consortium, Rackham, O. J. L., Firas, J., Fang, H., Oates, M. E., Holmes, M. L., Knaupp, A. S., Suzuki, H., Nefzger, C. M., Daub, C. O., et al. (2016) · Nature Genetics · doi:10.1038/ng.3487 · Cited by 290
“Mogrify predicted NANOG, OCT4 and SOX2 as the top three transcription factors for this conversion, a combination that has also been experimentally validated25.”
InfluentialSingle cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells
Narsinh, K. H., Sun, N., Sanchez-Freire, V., Lee, A. S., Almeida, P., Hu, S., Jan, T., Wilson, K. D., Leong, D., Rosenberg, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44635 · Cited by 273
“Introduction Human induced pluripotent stem cells (hiPSCs) can be derived from differentiated somatic cells by a reprogramming process involving overexpression of a key set of transcription factors (1, 2).”
BackgroundResultPapapetrou, E. P., Tomishima, M. J., Chambers, S. M., Mica, Y., Reed, E., Menon, J., Tabar, V., Mo, Q., Studer, L., & Sadelain, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904825106 · Cited by 286
“iPSC clones may fail to differentiate as a consequence of incomplete vector silencing (2, 13, 20).”
BackgroundmiR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4
Okuda, H., Xing, F., Pandey, P. R., Sharma, S., Watabe, M., Pai, S. K., Mo, Y.-Y., Iiizumi-Gairani, M., Hirota, S., Liu, Y., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2037 · Cited by 285
“KLF4 is one of IPS genes that are required for maintenance of stemness of progenitor cells (27, 28).”
Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
Johnsen, J. I., Dyberg, C., & Wickström, M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00009 · Cited by 277
“Lin28B has also been shown to be important for the maintenance of stemness during embryonic development (Yu et al., 2007).”
BackgroundTissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models
Caddeo, S., Boffito, M., & Sartori, S. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00040 · Cited by 285
Tbx3 improves the germ-line competency of induced pluripotent stem cells
Han, J., Yuan, P., Yang, H., Zhang, J., Soh, B. S., Li, P., Lim, S. L., Cao, S., Tay, J., Orlov, Y. L., et al. (2010) · Nature · doi:10.1038/nature08735 · Cited by 285
Zhang, J., Nuebel, E., Wisidagama, D. R. R., Setoguchi, K., Hong, J. S., Van Horn, C. M., Imam, S. S., Vergnes, L., Malone, C. S., Koehler, C. M., et al. (2012) · Nature Protocols · doi:10.1038/nprot.2012.048 · Cited by 282
Periodontal Ligament Stem Cells: Current Status, Concerns, and Future Prospects
Zhu, W., & Liang, M. (2015) · Stem Cells International · doi:10.1155/2015/972313 · Cited by 277
“Because ESC research is often hampered by ethical concerns, somatic cells can be transformed into iPSCs, which are equivalent to ESCs in many aspects, by transfecting OCT3/4, SOX2, KLF4, and C-MYC [52] or OCT4, SOX2,NANOG, and LIN28 [53].”
BackgroundLei, Y., Gojgini, S., Lam, J., & Segura, T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.103 · Cited by 278
“This results in cells that exhibit similar characteristics to ESCs [7–11].”
ResultImmaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?
Veerman, C. C., Kosmidis, G., Mummery, C. L., Casini, S., Verkerk, A. O., & Bellin, M. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0533 · Cited by 265
“Moreover, the ability to reprogram adult somatic cells into a pluripotent state as induced pluripotent stem cells (iPS cells or iPSCs) [5,6], coupled with advances in methods for genetic engineering [7] now make it possible to study patient- and disease-specific cardiac cells carrying specific (disease related) mutati…”
Defined factors induce reprogramming of gastrointestinal cancer cells
Miyoshi, N., Ishii, H., Nagai, K.-I., Hoshino, H., Mimori, K., Tanaka, F., Nagano, H., Sekimoto, M., Doki, Y., & Mori, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912407107 · Cited by 280
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9680-6 · Cited by 283
“Since the establishment of human iPSCs in 2007 [2, 3], many attempts have been made to produce iPSCs more efficiently and safely.”
BackgroundNative human adipose stromal cells: localization, morphology and phenotype
Maumus, M., Peyrafitte, J.-A., D'Angelo, R., Fournier-Wirth, C., Bouloumié, A., Casteilla, L., Sengenès, C., & Bourin, P. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.269 · Cited by 262
Rethinking Differentiation: Stem Cells, Regeneration, and Plasticity
Sánchez Alvarado, A., & Yamanaka, S. (2014) · Cell · doi:10.1016/j.cell.2014.02.041 · Cited by 276
Isolation and Characterization of Pluripotent Human Spermatogonial Stem Cell-Derived Cells
Kossack, N., Meneses, J., Shefi, S., Nguyen, H. N., Chavez, S., Nicholas, C., Gromoll, J., Turek, P. J., & Reijo-Pera, R. A. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0439 · Cited by 281
“Notably, these cells are not genetically modified as is required for generation of induced pluripotent stem cells that can be derived from fetal or adult somatic cells [41–43].”
Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications
Yoshida, Y., & Yamanaka, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.311080 · Cited by 264
“Human iPSCs were established similarly by introducing the same or another set of transcription factors.(10,11)”
MethodThe prenatal origins of cancer
Marshall, G. M., Carter, D. R., Cheung, B. B., Liu, T., Mateos, M. K., Meyerowitz, J. G., & Weiss, W. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3679 · Cited by 281
Wang, S., Du, Y., Zhang, B., Meng, G., Liu, Z., Liew, S. Y., Liang, R., Zhang, Z., Cai, X., Wu, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.004 · Cited by 281
Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation
Bratt‐Leal, A. M., Carpenedo, R. L., & McDevitt, T. C. (2009) · Biotechnology Progress · doi:10.1002/btpr.139 · Cited by 271
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.